Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, 371-8511, Japan.
Faculty of Education, Ikuei University, Takasaki, 370-0011, Japan.
Lipids Health Dis. 2019 Apr 4;18(1):84. doi: 10.1186/s12944-019-1014-7.
Two important regulators for circulating lipid metabolisms are lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL). In relation to this, glycosylphosphatidylinositol anchored high-density lipoprotein binding protein 1 (GPIHBP1) has been shown to have a vital role in LPL lipolytic processing. However, the relationships between skeletal muscle mass and lipid metabolism, including LPL, GPIHBP1, and HTGL, remain to be elucidated. Demonstration of these relationships may lead to clarification of the metabolic dysfunctions caused by sarcopenia. In this study, these relationships were investigated in young Japanese men who had no age-related factors; participants included wrestling athletes with abundant skeletal muscle.
A total of 111 young Japanese men who were not taking medications were enrolled; 70 wrestling athletes and 41 control students were included. The participants' body compositions, serum concentrations of lipoprotein, LPL, GPIHBP1 and HTGL and thyroid function test results were determined under conditions of no extreme dietary restrictions and exercises.
Compared with the control participants, wrestling athletes had significantly higher skeletal muscle index (SMI) (p < 0.001), higher serum concentrations of LPL (p < 0.001) and GPIHBP1 (p < 0.001), and lower fat mass index (p = 0.024). Kruskal-Wallis tests with Bonferroni multiple comparison tests showed that serum LPL and GPIHBP1 concentrations were significantly higher in the participants with higher SMI. Spearman's correlation analyses showed that SMI was positively correlated with LPL (ρ = 0.341, p < 0.001) and GPIHBP1 (ρ = 0.309, p = 0.001) concentration. The serum concentrations of LPL and GPIHBP1 were also inversely correlated with serum concentrations of triglyceride (LPL, ρ = - 0.198, p = 0.037; GPIHBP1, ρ = - 0.249, p = 0.008). Serum HTGL concentration was positively correlated with serum concentrations of total cholesterol (ρ = 0.308, p = 0.001), low-density lipoprotein-cholesterol (ρ = 0.336, p < 0.001), and free 3,5,3'-triiodothyronine (ρ = 0.260, p = 0.006), but not with SMI.
The results suggest that increased skeletal muscle mass leads to improvements in energy metabolism by promoting triglyceride-rich lipoprotein hydrolysis through the increase in circulating LPL and GPIHBP1.
脂蛋白脂肪酶(LPL)和肝甘油三酯脂肪酶(HTGL)是循环脂质代谢的两个重要调节因子。与此相关,糖基磷脂酰肌醇锚定高密度脂蛋白结合蛋白 1(GPIHBP1)已被证明在 LPL 脂解加工中具有重要作用。然而,骨骼肌质量与脂质代谢之间的关系,包括 LPL、GPIHBP1 和 HTGL,仍有待阐明。这些关系的证明可能有助于阐明肌少症引起的代谢功能障碍。在这项研究中,我们研究了没有年龄相关因素的年轻日本男性,参与者包括骨骼肌丰富的摔跤运动员。
共纳入 111 名未服用药物的年轻日本男性,其中 70 名摔跤运动员和 41 名对照组学生。在没有极端饮食限制和运动的情况下,测定参与者的身体成分、脂蛋白、LPL、GPIHBP1 和 HTGL 血清浓度以及甲状腺功能试验结果。
与对照组相比,摔跤运动员的骨骼肌指数(SMI)显著更高(p<0.001),血清 LPL(p<0.001)和 GPIHBP1(p<0.001)浓度更高,脂肪量指数(p=0.024)更低。Kruskal-Wallis 检验和 Bonferroni 多重比较检验显示,SMI 较高的参与者血清 LPL 和 GPIHBP1 浓度显著更高。Spearman 相关分析显示,SMI 与 LPL(ρ=0.341,p<0.001)和 GPIHBP1(ρ=0.309,p=0.001)浓度呈正相关。LPL 和 GPIHBP1 的血清浓度也与甘油三酯的血清浓度呈负相关(LPL,ρ=-0.198,p=0.037;GPIHBP1,ρ=-0.249,p=0.008)。血清 HTGL 浓度与总胆固醇(ρ=0.308,p=0.001)、低密度脂蛋白胆固醇(ρ=0.336,p<0.001)和游离 3,5,3'-三碘甲状腺原氨酸(ρ=0.260,p=0.006)浓度呈正相关,但与 SMI 无关。
结果表明,增加骨骼肌质量通过增加循环 LPL 和 GPIHBP1 促进富含甘油三酯的脂蛋白水解,从而改善能量代谢。